Kieran O'Kane, Chief Commercial Officer at BIODESIX INC (BDSX), sold 298 shares at $8.15 ($2K) on 2026-01-16, disclosed to the SEC on 2026-01-20.
Open-market sale of $2k BDSX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BDSX | SELL | 2025-11-13 | $191 | — | Filing → |
| BDSX | SELL | 2025-08-14 | $200 | — | Filing → |
| BDSX | SELL | 2025-05-13 | $169 | — | Filing → |